[{"_1":2,"_123":-5,"_124":-5},"loaderData",{"_3":4,"_26":27},"root",{"_5":6,"_17":10,"_18":19,"_20":21,"_22":10,"_23":-5,"_24":-5,"_25":10},"user",{"_7":8,"_9":10,"_11":10,"_12":-5,"_13":-5,"_14":15,"_16":-5},"roles",[],"isAuthenticated",false,"isPremium","planName","subscriptionStatus","featureFlags",{},"insightsBudget","isDevelopmentHost","userPreferences",{},"recaptchaSiteKey","6LcvOJcUAAAAAHsB-gPGfGktcRlKpH7OTIU_dMTD","isImpersonating","impersonation","affiliateStatus","isFreedomPortal","routes/v2/article/layout",{"_28":29,"_30":31},"notFound",true,"relatedArticles",[32,76,88,99,111],{"_33":34,"_35":36,"_37":38,"_39":40,"_41":42,"_43":44,"_45":46,"_47":48,"_49":50,"_51":52,"_53":54,"_55":56,"_57":58,"_59":60,"_61":62,"_63":64,"_65":66,"_67":68,"_69":70,"_71":72,"_73":74,"_75":74},"mediaId",6383559,"mediaKeyId","2124128-fa298916fa621841c0ed726460fd84cc","parentId",2124128,"title","Committee refers HB 1629 and HB 2088 to Courts Committee","audioSeconds",50,"startMs",1035000,"endMs",1085000,"viewUrl","/Search/View?dp=1&key=2124128-fa298916fa621841c0ed726460fd84cc&start=1035&end=1085","thumbnailUrl","https://assets.pipeline.soar.com/2124128-fa298916fa621841c0ed726460fd84cc/thumbnail_1035000.jpg","articleUrl","/articles/6383559/Virginia/Committee-refers-HB-1629-and-HB-2088-to-Courts-Committee","mediaUrl","https://secure.pipeline.soar.com/6383559-a5fa1993f2a8b0da044982eeb4b5cc53/orig.mp4?Expires=1771029957&Signature=di1DG1NQHMqqcKU2kxvkxT6j6AvR~62LMKSFj6mWMAILH1S359hYfO621chSeBM87rDL51mnHt7IZaB~fAiSus99pJAEq0G2GtyMeHfifsptvNKY4qLLWEmgFxbgxKL7ZCkWGftkuQCR0KwLBL97iTauf3llFFJu9CnbYdWRM1gH4bP3mhBT~DZQsCdxgAwwD-vkqdDMm9Rihodqgd1gjTgvmiGNbKwc35TgoXCw8T8WH7-xGUMyJawrdbHiO1pXfXvMaPO4oygXK7g-Rnu3l9My0NL3u7YkybX0xnMCcmHkxMkRi2Py13dqfSTMxHNwGGAUaUfzqYPs6EJlKotuvw__&Key-Pair-Id=KUT5TJCACFTXG","author","Virginia Legislature","date","2025-01-16T00:00:00Z","article","The committee referred two bills to the Courts Committee during routine administrative action. Members moved and seconded referral of HB 1629 and HB 2088 and the chair called for the question; committee members said \"aye,\" and the chair announced both bills were referred with no opposition recorded in the hearing excerpt.

No substantive discussion of the bills' text or policy implications was included in the available transcript excerpt; the committee action was presented as an administrative referral at the start of the session.","mediaType","Video","parentTitle","Health and Human Services Thursday, Jan 16, 2025 8:28 AM - 9:15 AM","oneSentenceSummary","Two bills, HB 1629 and HB 2088, were moved, seconded and referred to the Courts Committee; the committee record in the transcript shows motions and unanimous assent with no recorded opposition and no further details on the measures in the hearing text.","taxTitle","2025 Legislature VA, Virginia","taxId",77687,"location","Virginia","headline","","shortSummary",{"_33":77,"_35":36,"_37":38,"_39":78,"_41":79,"_43":80,"_45":81,"_47":82,"_49":83,"_51":84,"_53":85,"_55":56,"_57":58,"_59":86,"_61":62,"_63":64,"_65":87,"_67":68,"_69":70,"_71":72,"_73":74,"_75":74},6383564,"Committee adopts annual bill to align state drug schedules with federal classifications, passes 22-0",99,1352000,1451000,"/Search/View?dp=1&key=2124128-fa298916fa621841c0ed726460fd84cc&start=1352&end=1451","https://assets.pipeline.soar.com/2124128-fa298916fa621841c0ed726460fd84cc/thumbnail_1352000.jpg","/articles/6383564/Virginia/Committee-adopts-annual-bill-to-align-state-drug-schedules-with-federal-classifications-passes-22-0","https://secure.pipeline.soar.com/6383564-5a8997d25acdf7171ada3083bdb43c5d/orig.mp4?Expires=1771029957&Signature=XZH8Z7oUshTsQCo5AHJ1BXra2Y1AQ0B84J3MvXQv1gmHpHtgx5NRMyP6wRG~deGGUHOYk2TThwoBJwU-vnUsXgVcx4o6ZOYTE2aWbKlS8GIq7xhAH~~pI05qA8wq8fi5uV5mNXwDES~VQWnHXQORR4a2lith1FIWKgNHHqdvZN5n-FeVRJoRK2gxAsBu0ALE-B6KWZIOKjEMwuQyy84nmpdQbGA~8Y1JaqRsMLDZjDoYgGlzcW~b9VteW5jrWLBnJKigAmSinyrPtb9IReugVbNqeX47YVWTk2QlB1~ErUargt6fEmNskT9gZ4SvWWyEt3TNdAIsIbdEIn52bpUd8Q__&Key-Pair-Id=KUT5TJCACFTXG","The committee unanimously approved HB 1587, the annual measure to add newly scheduled federal controlled substances to Virginia's state schedules, by a recorded vote of 22 to 0. The sponsor described the federal scheduling process and said Virginia typically follows the DEA's scheduling decisions but must adopt them into state code to make changes permanent.

The patron explained that the DEA classifies new substances into schedules based on abuse potential and legitimate medical purpose and that Virginia maintains consistency by adopting those federal designations. The sponsor said this is the 22nd year he has voted on similar legislation.

No witnesses registered opposition during the hearing and the clerk recorded the committee vote as 22-0 in favor of reporting the bill.","HB 1587, an annual bill to add new controlled substances to Virginia's schedules consistent with DEA classifications, passed committee on a unanimous 22-0 vote.",{"_33":89,"_35":36,"_37":38,"_39":90,"_41":91,"_43":92,"_45":80,"_47":93,"_49":94,"_51":95,"_53":96,"_55":56,"_57":58,"_59":97,"_61":62,"_63":64,"_65":98,"_67":68,"_69":70,"_71":72,"_73":74,"_75":74},6383568,"Committee amends HB 1582 to clarify pharmacist prescribing under collaborative practice agreements, then refers bill to courts",226,1126000,"/Search/View?dp=1&key=2124128-fa298916fa621841c0ed726460fd84cc&start=1126&end=1352","https://assets.pipeline.soar.com/2124128-fa298916fa621841c0ed726460fd84cc/thumbnail_1126000.jpg","/articles/6383568/Virginia/Committee-amends-HB-1582-to-clarify-pharmacist-prescribing-under-collaborative-practice-agreements-then-refers-bill-to-courts","https://secure.pipeline.soar.com/6383568-e7643798304192755f2a8ce3d5ea65b7/orig.mp4?Expires=1771029957&Signature=Jz0zSNjJO39axk5zEE8VE-hkHwCbV82CFoHTY0ejVPvlepOCVj~-jKW5JZS72n8rstTHX9Cnkrd8EudD8hN7mKzAip2DexEzp-9e3TanJWPbBFoZpDZQFOo4BBludNex~pYIsvJsygjMNhSA8Eb52-8DBx2S2QiursmUMnbqUoW4BHkkMXpqmrvLjOx7YRViJVqWDsF2Zhd6IppLj-6E48CkUXTKD8mK78z2dP1DDQiex2V0a~35qv6Rtw1xMI0legtMZsVyO6lgG0Tjoo4UFSjutw8ITiCwqXdfG02e-UXmXUUjTe64GpM44QMIUB~V7FIF4~F-KDtrBgWjM-mmAw__&Key-Pair-Id=KUT5TJCACFTXG","Committee members amended HB 1582 to clarify that pharmacists may \"prescribe\" drugs under collaborative practice agreements rather than merely \"implement\" therapy, a change the patron said is intended to satisfy DEA terminology and permit pharmacists to prescribe Suboxone in a planned substance‑use clinic in Southwest Virginia.

Delegate Waxman, the bill patron, explained the amendment: the bill already authorized collaborative practice agreements between pharmacists and prescribers, but the Drug Enforcement Administration does not recognize the phrase \"implement therapy\" for controlled substances. Waxman said the amendment replaces \"implement\" with \"prescribing\" and clarifies which licensed prescribers may participate (licensed physician, podiatrist, advanced practice registered nurse or physician assistant). He explained the sponsors had filed a secondary amendment to add podiatrists after an omission was identified.

Waxman said he had letters of support from the local pharmacist involved in the proposed clinic and from the Department of Corrections' director of health services. Committee members asked no follow-up substantive questions, no public opposition was recorded, and members moved and seconded the amended referral; the clerk recorded the referral to the Courts Committee for further review.

The committee did not record an individual roll-call tally for the referral in the available transcript text; the outcome recorded in the hearing was that HB 1582 was referred to the Courts Committee as amended.","HB 1582 was amended to replace the term 'implement' with 'prescribing' in collaborative practice language to allow pharmacists to prescribe Suboxone under physician agreements; the committee approved the amendment and referred the bill for further review.",{"_33":100,"_35":36,"_37":38,"_39":101,"_41":102,"_43":103,"_45":104,"_47":105,"_49":106,"_51":107,"_53":108,"_55":56,"_57":58,"_59":109,"_61":62,"_63":64,"_65":110,"_67":68,"_69":70,"_71":72,"_73":74,"_75":74},6383573,"Committee votes unanimously to refer newborn screening bill to appropriations after advocates highlight rare-disease cases",536,2253000,2789000,"/Search/View?dp=1&key=2124128-fa298916fa621841c0ed726460fd84cc&start=2253&end=2789","https://assets.pipeline.soar.com/2124128-fa298916fa621841c0ed726460fd84cc/thumbnail_2253000.jpg","/articles/6383573/Virginia/Committee-votes-unanimously-to-refer-newborn-screening-bill-to-appropriations-after-advocates-highlight-rare-disease-cases","https://secure.pipeline.soar.com/6383573-af7a0c8b7f8e88578a17d77602178cc2/orig.mp4?Expires=1771029957&Signature=PYN1WcToyupsFPMHqatnpZ2Et3iE5dSKRIwwTViD6qBOeIawz0WX4M73cVpW3t5UrRWWDaGFU7-XlDG2slwvqx1kd5O9JTCnXIqFMt-t3L1hxJeOVnwEd5dHkeRe1KWdDnTFca4hvPgvWeZbWUv32QLCrkFoVb7BdJD1Yk0hzMFkbvpezs-eMdCSb~8aMea97wVp27ByekmtFIa5zZlUz5AE93tkXiwsoZVgqZYJa3Y1sWtmvfvLj7xzO9tLhotMUBOzflhTI4pIfz0pneP~ZadGk1CFzOlFdc3Ao-UXq1g6tLv499fBl~SuTSN1ukLjq7nN-CM4z8NNbFsZj4~nvw__&Key-Pair-Id=KUT5TJCACFTXG","A House committee voted unanimously, 22-0, to report HB 1782 to the Appropriations Committee after testimony from rare-disease advocates, hospitals and parents. The bill would require the Virginia Department of Health to automatically consider disorders placed on the federal Recommended Uniform Screening Panel (RUSP) for the Commonwealth newborn screening program and set deadlines for evaluation and implementation.

Delegate Sullivan, the bill patron, told the committee Virginia performs more than 4 million newborn screening tests yearly through the Division of Consolidated Laboratory Services and the Department of Health, and said HB 1782 would codify an evidence-driven process already in practice. Dylan Simon of the EverLife Foundation said the bill would remove the burden from patient communities to initiate consideration of new disorders and called it an important step to ensure early diagnosis and access to life‑saving therapies.

Brent Rawlings of the Virginia Hospital and Healthcare Association described the program's costs and the financial implications of adding conditions. He said the two disorders most recently added in 2020 — spinal muscular atrophy (SMA) and X-linked adrenoleukodystrophy (X-ALD) — cost about $1.5 million and $1.25 million, respectively, and that the per-birth fee was adjusted to cover program expenses. A parent who addressed the committee described a daughter born two months before Virginia added SMA to the panel; he said early detection and treatment for SMA occurred in \"hours, days, and weeks,\" and that missing newborn screening delayed access to treatment.

Members asked clarifying questions about the bill's timelines and the role of the advisory council; the sponsor and witnesses said the measure codifies existing review practices and leaves time to resolve technical questions with the Department of Health and other stakeholders before final implementation. The committee moved and seconded a motion to report the bill to Appropriations; the clerk opened the roll and the motion carried 22-0.

The bill, as reported, directs the Department of Health to evaluate nominated disorders within 12 months and implement testing within 36 months after designation, and it includes language intended to ensure resources are available for additions to the panel. The committee record shows no opposition votes.","A House committee voted 22-0 to refer HB 1782 to appropriations. The bill would require Virginia to automatically consider disorders listed on the federal Recommended Uniform Screening Panel (RUSP) for inclusion in the Commonwealth newborn screening program and set timelines for evaluation and implementation.",{"_33":112,"_35":36,"_37":38,"_39":113,"_41":114,"_43":115,"_45":116,"_47":117,"_49":118,"_51":119,"_53":120,"_55":56,"_57":58,"_59":121,"_61":62,"_63":64,"_65":122,"_67":68,"_69":70,"_71":72,"_73":74,"_75":74},6383577,"House committee reports Virginia Right to Contraception Act to the floor after hours of testimony",750,1426000,2176000,"/Search/View?dp=1&key=2124128-fa298916fa621841c0ed726460fd84cc&start=1426&end=2176","https://assets.pipeline.soar.com/2124128-fa298916fa621841c0ed726460fd84cc/thumbnail_1426000.jpg","/articles/6383577/Virginia/House-committee-reports-Virginia-Right-to-Contraception-Act-to-the-floor-after-hours-of-testimony","https://secure.pipeline.soar.com/6383577-c47c6eba62784cbbfd658fada228e11a/orig.mp4?Expires=1771029957&Signature=StzX8Cfk6CqP1HDhccvPud70jFFN4g1Zz7u0WPWh2x65vgKKC06WNZm50iSlMg4ZA4M6qA6QL1mFnJzjqCJdAFwPqZL54HTC835x7puZrSZ4GJESAS64SpQSuNfhwP-RW9XdWD0SNaxBi6z540HmCdKUYv-rKws5p21FHBdgFm1O6hTaPp-MEwX0DWzlcWkkmTHv3QJjoOmUe504GZjvfg91mMtXLmbOSd8iW-AuBD~EhIBch1dcG30P~Pc~RH51qAR-9frbEv5jab20gwm2kMCYu3Gd2oew8yJfOW3eOecD9DX1LCZbqFqY3pkEdbRIB20KPDuAVSGj6bPoVyT~Zg__&Key-Pair-Id=KUT5TJCACFTXG","A House committee voted 15-7 to report HB 1716, the Virginia Right to Contraception Act, to the floor after an hour-plus of testimony and questioning from members. The bill would bar state and local actors from restricting access to FDA-approved contraceptives and related clinical care.

Supporters told the committee the measure would protect established medical uses of contraceptives, including treating endometriosis and polycystic ovarian syndrome, and keep those decisions between patients and clinicians. Nicole Lauter, representing the American College of Obstetricians and Gynecologists, said, \"We are fully in support of this legislation.\" Doctor Ivanti Jayavira of the Reproductive Health Access Project testified that contraception is often a medical treatment and said, \"I need to be allowed to perform my job. I need to be able to practice medicine without any kind of interference.\" Several medical students and clinicians, and representatives from Planned Parenthood Advocates of Virginia, Progress Virginia and the League of Women Voters of Virginia, also spoke in favor.

Opponents raised concerns about how the bill defines who may provide care and the role of parental consent. Jeff Caruso of the Virginia Catholic Conference said the bill's definition of covered health professionals \"includes pharmacist, dentist, optometrist, podiatrist, chiropractors, physical therapists, psychologists, social workers, marriage and family therapists, and others,\" and argued that scope could allow minors to obtain certain services without parental involvement. Caruso also said the bill's definition of contraception could encompass sterilization and that the measure could conflict with existing conscience protections.

Patron Sia Price, the bill sponsor, told the committee the bill would not change existing statutes on minors or replace current religious-conscience frameworks; she said the measure's purpose is to prevent state or local interference with access. After members questioned the language and heard from the public, Delegate Kathy Tran moved to report the bill to the floor; the motion carried on a vote of 15 yes and 7 no.

The committee hearing included multiple public witnesses who described clinical and family impacts of limiting contraceptive access and urged passage; witnesses included clinicians, a clinic worker and advocacy groups. The committee did not adopt technical amendments on the floor; the version reported is the bill as presented. The bill now goes to the full House for further consideration.","A Virginia House committee voted 15-7 to report HB 1716, the Virginia Right to Contraception Act, to the full House after testimony from medical groups, patients and faith-based opponents about minors, provider scope and conscience protections.","actionData","errors"]

Article not found

Committee refers HB 1629 and HB 2088 to Courts Committee

Committee adopts annual bill to align state drug schedules with federal classifications, passes 22-0

Committee amends HB 1582 to clarify pharmacist prescribing under collaborative practice agreements, then refers bill to courts

Committee votes unanimously to refer newborn screening bill to appropriations after advocates highlight rare-disease cases

House committee reports Virginia Right to Contraception Act to the floor after hours of testimony